Analgesics - Bosnia and Herzegovina

  • Bosnia and Herzegovina
  • In 2024, the revenue in the Analgesics market in Bosnia and Herzegovina amounts to US$26.31m.
  • The market is projected to experience an annual growth rate of 5.47% (CAGR 2024-2029).
  • When compared to other countries worldwide, the in the United States generates the highest revenue in the Analgesics market, reaching US$7,243.00m in 2024.
  • Considering the total population, in Bosnia and Herzegovina generates US$8.24 in revenue per person in 2024.
  • The demand for over-the-counter analgesics is rising in Bosnia and Herzegovina due to an aging population and increasing prevalence of chronic pain.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Bosnia and Herzegovina is witnessing significant growth and development.

Customer preferences:
Customers in Bosnia and Herzegovina have shown a growing preference for analgesics as a means to manage pain and discomfort. This can be attributed to various factors such as an aging population, increased awareness about self-care and health, and the availability of a wide range of analgesic products in the market. Customers are also seeking convenience and ease of use when it comes to analgesics, leading to a rise in demand for products such as topical analgesics and pain relief patches.

Trends in the market:
One of the key trends in the Analgesics market in Bosnia and Herzegovina is the growing popularity of natural and herbal analgesics. Customers are increasingly looking for alternative and natural remedies for pain relief, which has led to the introduction of a variety of herbal analgesic products in the market. This trend is driven by the belief that natural products are safer and have fewer side effects compared to conventional analgesics.Another trend in the market is the increasing availability and use of over-the-counter (OTC) analgesics. OTC analgesics are easily accessible to customers without the need for a prescription, which has contributed to their popularity. Customers value the convenience and affordability of OTC analgesics, making them a preferred choice for managing mild to moderate pain.

Local special circumstances:
Bosnia and Herzegovina has a relatively high prevalence of chronic pain conditions, which has fueled the demand for analgesics in the market. Conditions such as arthritis, back pain, and migraines are common among the population, leading to a higher need for pain management solutions. This has created a favorable environment for the growth of the Analgesics market in the country.Additionally, the healthcare system in Bosnia and Herzegovina is evolving, with an increased focus on self-care and patient empowerment. As a result, customers are taking a more proactive approach towards managing their health, including the use of analgesics for pain relief. This shift in mindset has contributed to the growth of the Analgesics market in the country.

Underlying macroeconomic factors:
The growing economy of Bosnia and Herzegovina has had a positive impact on the Analgesics market. As disposable incomes rise, customers have more purchasing power to spend on healthcare products, including analgesics. This has led to an increase in demand for analgesics, as customers are able to afford these products more easily.Furthermore, the government's focus on improving healthcare infrastructure and services has also contributed to the growth of the Analgesics market. With better access to healthcare facilities and services, customers are more likely to seek medical advice and treatment for their pain, leading to an increased demand for analgesics.In conclusion, the Analgesics market in Bosnia and Herzegovina is experiencing growth and development due to factors such as customer preferences for pain management, the popularity of natural and herbal analgesics, the availability of OTC products, the prevalence of chronic pain conditions, the evolving healthcare system, and the growing economy. These factors are driving the demand for analgesics and shaping the market landscape in the country.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)